Respiratory Infections

West and Central African nations have been developing infrastructure to combat ebola, malaria, malnutrition, and more.

A modeling study from Imperial College shows the COVID-19 pandemic may require balancing with other infectious disease priorities.

Tens of thousands of patients were prescribed the anti-malarial drugs in the early weeks of the pandemic, a statistic that concerns public health officials.

Heparin may lower the odds of SARS-CoV-2 infection, according to investigators from the Rensselaer Polytechnic Institute.

New study findings shed light on the positive effects of baloxavir for preventing influenza spread in household settings.

Following an outbreak of both COVID-19 and H1N1 influenza, Parisian hospital admissions for Kawasaki disease increased.

The mRNA-1273 vaccine candidate from Moderna will progress to a phase 3 trial in adults later this summer.

A modeling study from Imperial College shows the pandemic may have significant effect on mortality among other infectious disease patients.

A modeling study from Imperial College shows the pandemic may have significant effect on mortality among other infectious disease patients.

Efforts to develop a COVID-19 vaccine must not skip important steps during clinical evaluation, experts explain.

Findings were announced during the special COVID-19 sessions of the virtual 23rd International AIDS Conference.

Over 200 scientists issued alert to medical community that COVID-19 is transmissible over longer distances via smaller aerosolized droplets.

Despite being within the age group at highest risk for severe SARS-CoV-2 infection, a recent survey suggests that the population is not inherently more willing to socially isolate.

How the inflammatory-based syndrome is affecting US children during the COVID-19 pandemic.

A discussion on how the pediatric inflammatory syndrome has begun to affect the US months into the pandemic.

A discussion with a Yale expert on what new CDC data shows.

Judith Feinberg, MD, FIDSA, describes ongoing investigation into the immune response from COVID-19.

A brief overview of our top stories.

Jonathan Spero, MD, discusses workplace safety in the time of SARS-CoV-2.

Recent concerns have been raised about a spike protein mutation in SARS-CoV-2. Are these fears grounded?

New recommendations are intended to aid biomedical firms in achieving licensure of a safe and effective vaccine.

Judith Feinberg, MD, FIDSA, describes surprising outcomes in many COVID-19 cases among people living with HIV.

A brief overview of our recent coverage.

Opaganib is set to be evaluated against SARS-CoV-2 in a multi-center, randomized, parallel arm, double-blind, placebo-controlled study.

The status of emergency departments in the city during the pandemic's migration west.